Study Comparing Glucocorticoid Injection at Myofascial Trigger Points Versus Joint Injection for Treating Hip Osteoarthritis in Adults 45 and Older

What this Trial Is About

Researchers are evaluating treatments for chronic musculoskeletal pain, focusing on hip osteoarthritis, which is common and significantly affects quality of life, especially in older adults. This study compares two types of glucocorticoid injections one at myofascial trigger points and another directly into the joint cavity. The goal is to see if the easier trigger point injection is as effective as the joint injection over the long term. Participants are randomly assigned to receive either a joint cavity injection or a myofascial trigger points injection, both using triamcinolone acetonide combined with lidocaine. The joint injection is given via an anterolateral approach with a specific mixture of lidocaine and corticosteroid, while the trigger point injection involves injecting each tender point with a small volume of solution using a fine needle. Treatments are followed by regular assessments. Participants will be monitored and evaluated at 2, 4, 8, 12, and 24 weeks after treatment, with follow-up lasting up to 2 years. Researchers will record pain scores using the Numeric Rating Scale NRS, assess joint function with WOMAC scores, gather patient impressions of change with the PGIC scale, and track any adverse reactions. This detailed follow-up aims to determine the long-term safety and effectiveness of both injection methods.

Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA)